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Diagnostic Ultrasound Safety Review
for Point-of-Care Ultrasound
Practitioners
Douglas L. Miller, PhD , Alyssa Abo, MD, Jacques S. Abramowicz, MD, Timothy A. Bigelow, PhD,
Diane Dalecki, PhD, Eitan Dickman, MD, John Donlon, Gerald Harris, PhD , Jason Nomura, MD,
American Institute of Ultrasound in Medicine Bioeffects Committee
Potential ultrasound exposure safety issues are reviewed, with guidance for pru-
dent use of point-of-care ultrasound (POCUS). Safety assurance begins with the
training of POCUS practitioners in the generation and interpretation of diagnos-
tically valid and clinically relevant images. Sonographers themselves should mini-
mize patient exposure in accordance with the as-low-as-reasonably-achievable
principle, particularly for the safety of the eye, lung, and fetus. This practice
entails the reduction of output indices or the exposure duration, consistent with
the acquisition of diagnostically definitive images. Informed adoption of POCUS
worldwide promises a reduction of ionizing radiation risks, enhanced cost-effec-
tiveness, and prompt diagnoses for optimal patient care.
Key Words—as low as reasonably achievable; diagnostic ultrasound safety; Food
and Drug Administration regulation; mechanical index; output display standard;
point-of-care ultrasound; safety of the eye, lung, and fetus; thermal index;
ultrasound bioeffects
Diagnostic ultrasound (US) has provided nonionizing radia-tion imaging for patient care for more than 50 years. In thepast, the typical hospital diagnostic US machines were large
cumbersome carts needing expert sonographers for production of
useful diagnostic images, similar to computed tomographic or
magnetic resonance imaging procedures. However, advances in
design of US machines have reduced the size, while technological
advances have improved image quality. In a radical departure from
past practices, diagnostic US can now be easily portable and even
“handheld”: carried to the patient and applied by physicians or other
trained individuals for an immediate assessment and diagnosis with
real-time discussion, leading to enhanced patient service. This
advance compares to the introduction and adoption of the iconic
physician’s stethoscope in the 19th century for auscultation and
provides physicians with versatile US imaging of virtually any part of
the body.1 This development has created a new medical topic of
point-of-care ultrasound (POCUS).2 The appearance of POCUS
research publications in the medical literature (PubMed) is rapidly
increasing (Figure 1) and testifies to its scientific validation and
growing importance in medical practice.
The use of POCUS has revolutionized the ability of clinicians
to diagnose patients’ conditions at the bedside rapidly and accu-
rately. There are virtually no specialties in the house of medicine
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that do not use US, either for diagnostic purposes or
procedural guidance, or both. Training programs in a
variety of fields and specialties offer advanced training
with this specific imaging modality, and increasingly,
US is incorporated into medical school curricula.
Ultrasound offers a radiation-free, portable, and cost-
effective means of imaging almost every part of
the body.
Point-of-Care Ultrasound Patient
Examinations
The rapidly expanding use of portable US machines
allows diagnostic US examinations to be performed
by the physician at the bedside.3–5 The total use is
impossible to determine because POCUS examina-
tions are performed in so many settings, often with-
out billing records and often routinely on a daily basis
to follow patient progress.6–8
Rather than the comprehensive US examination
that typically is performed in the radiology, obstetrics
and gynecology, or cardiology suite, POCUS provides
a rapid answer to a specific clinical question. The ver-
satility of US is extensive; see Table 1 for a list of clin-
ical conditions that potentially can be ascertained
with US. For example, appropriately trained emer-
gency physicians can effectively use US to accurately
diagnose the conditions of patients who present to
the emergency department, including those with con-
ditions related to early pregnancy,9 possible pericar-
dial effusion,10 abdominal aortic aneurysm,11
undifferentiated shortness of breath,12 and vision loss
with retinal detachment13 and those patients who
have been traumatically injured.14 The ability to per-
form and interpret these US examinations allows cli-
nicians to diagnose potentially life-threatening
conditions in a timely manner. In addition to the use
of US in advanced health care environments, POCUS
can be particularly beneficial in resource-poor loca-
tions. This modality can substantially alter manage-
ment in places where other types of imaging are not
available.15,16 As an increasing number of physicians
graduate from medical schools with knowledge of
how to incorporate US into their clinical practices, it
is expected that the use of this technology will con-
tinue to grow in a wide variety of health care settings.
Similar to adult medicine, pediatrics exemplifies
the broad scope of POCUS being used in several dis-
ciplines, such as critical care, emergency medicine,
anesthesia, surgical subspecialties, as well as outpa-
tient and inpatient pediatrics. Furthermore, its use is
being expanded to new environments such as urgent
care. As the first imaging examination for many
patients, POCUS is invaluable, as it provides real-time
data that can be integrated into medical decision mak-
ing. In addition, it has become an integral part of
numerous procedures, including central and periph-
eral vascular access, incision and drainage of soft tis-
sue disorders, nerve blocks, lumbar punctures, and
bladder catheterization, among others. Furthermore,
POCUS can be used either once or in an ongoing
manner to monitor patients because of the lack of
any accumulating dose effect (in contrast to ionizing
radiation).
Benefits of POCUS are appreciated and endorsed
by various societies, including the World Federation
for Ultrasound in Medicine and Biology,17 the Ameri-
can College of Emergency Medicine,18 the Society of
Critical Care Medicine,19,20 and the American Acad-
emy of Pediatrics,21 among others. However, the con-
sideration of possible risks related to US exposure
often is brief and lacking in rationale for safety guid-
ance. Medical US originated as a means for tissue
modification, and numerous applications of US for
therapeutic purposes have been developed and are in
extensive use.22 Diagnostic US examinations must be
Figure 1. Plot of the number of citations returned in a PubMed
search for “point-of-care ultrasound” for each the last 15 years (*up
to November 2019). The rapid development of POCUS research lit-
erature testifies to its growing importance in medical practice.
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configured carefully to avoid possible adverse conse-
quences for the patient, through United States Food
and Drug Administration (FDA) regulation and
application of sonographer training.
The nonionizing radiation safety framework cre-
ated by the FDA for ensuring the safe use of diagnos-
tic US with guideline upper limits on acoustic output
has proven its worth as a flexible and effective sys-
tem.23 There have been no established occurrences of
patient injury by diagnostic US.24,25 However, diag-
nostic US cannot be considered perfectly safe because
of uncertainties about exposure dosimetry and poten-
tial injurious bioeffects. The safety issues are similar
to those for all diagnostic US, but POCUS presents a
new arena for ensuring the safe use of diagnostic
US. The purpose of this article is to briefly review
and discuss potential US exposure safety issues and to
outline guidance for prudent use of POCUS. As this
was a review of existing literature and did not require
the use of animals or patient data, ethical approval
and a request for obtaining informed consent were
not required.
Background of Diagnostic US Safety
Considerations
Thermal and nonthermal physical mechanisms are
operative during US exposure.26,27 There is essentially
no risk of genetic injury from US (which exists for
Table 1. List of Clinical Conditions That Can Be Potentially
Ascertained With US at the Bedside
Head
Skull fracture
Neonatal interventricular hemorrhage
Transcranial Doppler
Ocular
Retinal detachment
Vitreous hemorrhage
Dilated optic nerve sheath (as manifestation of elevated
intracranial pressure)
Globe rupture
Retrobulbar hemorrhage
Face
Fluid in sinuses
Peritonsillar abscess
Neck
Lymphadenopathy vs abscess
Thyroid masses
Orotracheal airway evaluation
Cardiac
Cardiac activity in setting of cardiac arrest
Pericardial effusion
Cardiac tamponade
Estimation of left ventricular ejection fraction
Focal wall motion abnormality
Preload and response to therapy
Evaluation of right ventricular function
Lung
Pleural effusion
Thoracentesis
Interstitial alveolar syndrome
Pulmonary edema
Pneumothorax
Acute heart failure
Pneumonia
Acute respiratory distress syndrome
Abdomen
Biliary disease
Hemoperitoneum
Small-bowel obstruction
Hernia
Appendicitis
Pyloric stenosis
Intussusception
Pelvic
Intrauterine pregnancy
Ectopic pregnancy
Ovarian masses
Ovarian torsion
Pelvic inflammatory disease
Genitourinary
Hydronephrosis
Testicular torsion
Bladder volume (urinary retention)
Procedural
Lumbar puncture
(Continues)
Table 1. Continued
Central venous catheterization
Peripheral vascular access
Regional anesthesia
Abscess localization
Paracentesis
Thoracentesis
Procedural complications
Musculoskeletal
Fractures: rib, extremity, skull
Tendon injuries
Vascular
Deep venous thrombosis
Superficial thrombophlebitis
Abdominal aortic aneurysm
Aortic dissection
Arterial thrombosis
Inferior vena cava (volume assessment)
Arterial access
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ionizing radiation in radiography, positron emission
tomography, and computed tomography). No univer-
sal dose quantity exists for US (such as the Gray, an
ionizing radiation absorption quantity). The diagnos-
tic US transducer emits pulses of US, which propa-
gate into the body. There is no exposure to the
operator or to bystanders because US does not trans-
mit into or propagate well in air, and the exposure is
only to the tissues interacting with the pulses. The
risks of specific biological effects induced by physical
mechanisms of tissue perturbation can be character-
ized by a threshold exposure response to the US out-
put and duration, with zero risk below a threshold
but an increasing impact above the threshold.26
Diagnostic US Exposure and Biological Effect
Mechanisms
Figure 2 illustrates a US pulse and its acoustic parame-
ters (measured in water). The waveform in Figure 2A
displays the US pressure wave (for reference, atmo-
spheric pressure is 0.1 MPa), which can be character-
ized by a peak rarefactional (negative) pressure
amplitude and a mean frequency. The pulse carries
momentum and has an intensity, calculated from the
pulse waveform in units of watts per square centimeter
(Figure 2B). Figure 2, C and D, illustrates the exposure
at a focal point during B-mode imaging, as the scanning
beam of US passes by the measurement point, for an
interval of a few pulse repetition periods, and for 2 full
image frames. Note that the US exposure is minimal
most of the time at a given point (eg, the location of
the small hydrophone used for pressure field measure-
ment) for scanned beams, so that the overall temporal-
average intensity is much lower than the pulse-average
intensity. Directed fixed-beam modes (M-mode and
pulsed Doppler mode) have much higher temporal-
average intensities than imaging modes because the
beam is not scanned. Ultrasonic energy is attenuated
Figure 2. Measured signals from a hydrophone in the scan plane of a 7.6-MHz diagnostic US transducer operated at an on-screen MI of 0.9
reduced (derated) to approximate the US values reaching a rat lung surface. The pulse waveform (A) is shown as pressure versus time,
which is used to calculate the instantaneous and pulse-average (horizontal line) intensities (B). In B, the length of the line indicates a pulse
duration of 320 nanoseconds. As the beam passes by the transducer, a series of pulses was received (C), which related to the scan rate
and the width of the beam. The pulse repetition frequency in C was 10 kHz (100-microsecond repetition period). The imaging was continu-
ous at 39 frames per second, which is seen as a brief series of pulses, as in C, repeated each 25.6 milliseconds (D) [Reproduced from Miller
DL, 2016].
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and absorbed in tissue depending on the absorption
coefficient of the tissue. The attenuation is moderate
for tissues such as liver, high for bone, and very high for
lung and typically increases in proportion to the mean
US frequency. Absorption of US in tissue results in an
exponential decrease in the US intensity as a function
of the propagation distance, which limits the penetra-
tion of US into the body and requires strong time-gain
compensation to display images with depth uniformity.
Even though the image appears uniform, the US expo-
sure is much less for distal portions of an image relative
to the focal point.
An assumption of safety for diagnostic US devices
was codified by the Medical Device Amendments of
1976 enacted by the United States Congress. This act
allowed for a simplified clearance process from the
FDA of new devices that were substantially equivalent
in safety and effectiveness to devices legally marketed
for the same applications before May 28, 1976. This
law led to development of protocols for measurement
of diagnostic US outputs, for the setting of guideline
upper limits on the output of diagnostic US devices,
and eventually for the creation of exposure indices.
Ultrasound machines are typically cleared for market-
ing by satisfying 510(k) premarket notification
requirements of the FDA, including recommended
upper limits to exposure parameters.23
The FDA identified the acoustic intensity of US as
the key quantity for regulation and adopted the spatial-
peak temporal-average intensity (ISPTA) in milliwatts
per square centimeter and the spatial-peak pulse-
average intensity (ISPPA) in watts per square centimeter
for characterization. These quantities are calculated
from measurements of the pulse pressure waveforms in
water using a hydrophone (Figure 2). Furthermore,
these measured values are used to estimate the peak
intensities in scanned tissue by adjusting for tissue
attenuation of the US, a process called derating. An
attenuation coefficient of 0.3 dB cm–1 MHz–1 was
adopted for this purpose as a conservative estimate of
attenuation (typical tissues have higher coefficients) for
safety. With the use of these methods and examination
of pre-1976 devices, a table of maximal parameters was
established for regulatory purposes. The values for the
derated ISPTA and ISPPA (ISPTA.3 and ISPPA.3) are listed
in Table 2 (mechanical index [MI] values are also
listed; see “The Real-time Display of Acoustic Output”
section below). Diagnostic US devices can be cleared
by the FDA by using these values via what is known as
the track 1 method of obtaining marketing clearance.
An important feature of this track 1 clearance method
is that different recommended limits were established
for different diagnostic US uses, with relatively low
values for fetal (obstetric) and ophthalmic uses.
The Real-time Display of Acoustic Output
Track 1 was unsatisfactory in that devices approved by
this method have no indication of the actual acoustic
output and exposure (except that they should be less
that the track 1 limits). In addition, the different values
of ISPTA.3 and ISPPA.3 for different uses were not based
on bioeffects studies because such information was not
available. Rather, to assist in the FDA’s decisions
regarding substantial equivalence in terms of safety,
they represented the maximum known output levels in
each category for devices on the market before 1976.28
Physicians can prescribe the use of an approved medi-
cal device for any examination deemed medically nec-
essary, and the extent to which the track 1 limits have
been followed in practice is uncertain. The US com-
munity, specifically the American Institute of Ultra-
sound in Medicine and the National Electrical
Manufacturers Association, worked with the FDA to
create a standard for displaying output indicators to
the sonographer that had defined relationships with
physical mechanisms for biological effects of US.29
This output display standard was used to create a track
3 method for device approval (there is no track
2 method). This science-based method revolutionized
the real-time assessment of exposure with direct
Table 2. Values of Recommended Maximal Output Exposure
Levels for the 2 FDA 510k-Approved Tracks, Adapted From the
FDA23
Use
ISPTA.3, mW
cm–2 TI
ISPPA.3, W
cm–2 MI
Preamendment acoustic output exposure levels (track 1)
Peripheral 720 190 1.9
Cardiac 430 190 1.9
Fetal and Othera 94 190 1.9
Ophthalmic 17 28 0.23
Output display standard recommendations (track 3)
Global Maximum 720 190 1.9
Ophthalmic 50 1.0 0.23
For both tracks, either the ISPPA.3 or the MI limits may be used.
aAbdominal, intraoperative, pediatric, small organ (breast, thyroid,
testes, etc), neonatal cephalic, and adult cephalic.
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relevance to safety and mostly eliminated the arbitrary
limits for uses of modern diagnostic US machines
(Table 2), which can generally perform most of the
different types of examinations.
The absorption of US energy in tissue leads to
local tissue heating, thereby introducing a thermal
mechanism with the potential for tissue injury. Ther-
mal indices (TIs) were created to indicate the potential
for heating during diagnostic US examinations.
Heating is dependent on the tissue absorption coeffi-
cient, the temporal-average intensity, and the duration
of the exposure at a particular point. As noted above,
the relatively high ISPPA is reduced by pulsing the US
to the ISPTA, and heating is further reduced by scan-
ning the US beam and by the relative motion of the
transducer and body. Heating is typically highest near
the transducer and at the beam focus. The values of
the TI capture the relative risk of thermal damage
mechanisms during the US exposure.30,31 Specifically,
TI values translate the acoustic output of the US
machine, quantified by the ISPTA, into an estimate of
the maximum potential temperature rise in degrees
Celsius in the tissue for long dwell times (ie, the poten-
tial worst case). Since the US absorption properties
vary based on tissue type, 3 different TI conditions
have been defined. These are the thermal index for soft
tissue (TIS) for soft tissue applications, the thermal
index for bone (TIB) when bone is expected to be pre-
sent in the imaging region of interest where the US
waves are focused, and the thermal index for the cra-
nium (TIC) when cranial bone is at the surface near
the US transducer. As a gauge of the bioeffect risk, TI
values of 0.7 or less can be considered inconsequential
for any duration, whereas values of 6 or greater indi-
cate a risk of tissue injury for 1 minute or longer dura-
tions and are discouraged by regulatory guidance.
There are also nonthermal mechanisms for effects
of US on tissues. Acoustic radiation force, generated as
US energy is absorbed, or acoustic radiation pressure,
generated when US reflects from a surface, can cause
perturbation of tissue.32 The physical perturbations
can be biologically substantial for high-intensity
focused US33 but are small for diagnostic US, with a
minimal expectation of harm. Radiation forces can lead
to fluid flow, which can be evident in a US image and
useful for distinguishing cysts from tumors.34 Radiation
forces can also cause local tissue displacement within
the focal beam and are the basis for elastographic
imaging. For the diagnostic US mode of shear wave
elastography, radiation force impulses generate tissue
displacement, which produces shear waves that are use-
ful for mapping tissue elasticity.35
Acoustic cavitation describes the interaction of a
US field with existing gas bodies or microbubbles and
is another mechanism by which US can produce bio-
logical effects in tissue. Diagnostic US pressure ampli-
tudes are sufficient (note that the peak negative
pressure in Figure 2A of about 2 MPa equals a nega-
tive stress of 20 times the magnitude of atmospheric
pressure) to warrant consideration of the possible
occurrence of US inertial cavitation, which is associ-
ated with several biological effects. Inertial cavitation
occurs when the US pulse interacts with a micro-
scopic cavitation nucleus, such as a microbubble of
gas. Above a peak rarefactional pressure amplitude
threshold, the nucleus expands explosively to 2 or
more times its initial diameter and then collapses
under the inertia of the inrushing fluid. This phenom-
enon can kill nearby biological cells and damage
blood vessels by mechanical processes and further-
more can cause damage by free radical generation
due to temperatures exceeding 5000 K at the collapse
point. By calculating the inertial cavitation thresholds
for many different microbubble sizes and US
frequencies,36 minimum thresholds (for optimal
nucleation) were found to increase as the square root
of the frequency. This finding guided the creation of
the on-screen MI, defined as the peak rarefactional
pressure amplitude (derated for tissue attenuation)
divided by the square root of the frequency and
adjusted to in situ exposure. From the theory, the
lowest threshold for inertial cavitation associated with
the optimal size of nuclei (or microbubble) occurs at
an MI of 0.4. However, the guideline upper limit of
output for diagnostic US devices was set at an MI of
1.9. Of note, this limit value was determined from
measurements of the output of a 2.25-MHz pre-1976
diagnostic US transducer and not by investigation of
bioeffects and specific safety considerations.28 The
MI value of 1.9 thus tolerates a theoretical risk of
cavitational bioeffects possible under optimal condi-
tions of nucleation for MIs in the range of 0.4 to 1.9.
Current FDA 510(k) guidance for the output dis-
play standard (track 3) methods is given in Table 2.
Manufacturers can choose to use either the ISPPA.3
value or the MI value as the upper limit. (Note that
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these limits are different, and, for example, the ISPPA.3
can exceed 190 W cm–2 at an MI of 1.9 for US frequen-
cies greater than about 2.25 MHz.). The 2 use catego-
ries are a global inclusion of most uses and ophthalmic
use. The difference in the tracks is noteworthy for
obstetric use: the ISPTA limit was effectively increased
from 94 to 720 mW cm–2. The newer diagnostic US
modes of elastography and contrast agent–enhanced
diagnostic US were not noted specifically in the regula-
tory recommendations. However, elastography complies
with the track 3 methods: the radiation force impulses
are relatively long but have an MI of less than 1.9 and
have an ISPTA.3 of less than 720 mW cm
–2 by virtue of
relatively low pulse repetition frequencies (eg, ≤1 Hz).
The modes used for contrast agent–enhanced diagnos-
tic US fall under the recommendations in Table 2, and
it is the microbubble-based agents that receive separate
FDA approval as injectable drugs (with recommended
US parameter limits noted in the package inserts). All
US machines that display the safety indices have an
explanatory document, Medical Ultrasound Safety,37
included in the operator’s instructions or other docu-
mentation as required by FDA regulations. The vendors
of diagnostic US equipment should help supply safety
information and to facilitate the prudent use of US
exposure whenever possible.
As-Low-as-Reasonably-Achievable Principle
The dosimetry and thresholds for biological effects
of diagnostic US are not definitively understood;
therefore, uncertainty exists as to the possible risks
of harm. Research on patient risks has been limited,
and in fact, it is impossible to prove the absence of
risk. Risk may depend on individual patient physio-
logic characteristics in addition to physical exposure
parameters. To prudently accommodate these uncer-
tainties, authoritative bodies assessing the diagnostic
US safety problem have recommended the imple-
mentation of the as-low-as-reasonably-achievable
(ALARA) principle.26,38,39 The operator is responsi-
ble for implementing ALARA during US examina-
tions. That is, the exposure duration and the acoustic
output should be kept as low as reasonably achiev-
able, consistent with collection of diagnostically
acceptable images. The exposure indices were devel-
oped for display on diagnostic US machines to
inform sonographers of exposure outputs related to
thermal and mechanical (nonthermal) mechanisms,
described above. As a benchmark low-risk condition,
diagnostic outputs (excluding ophthalmology) with
an MI of less than 0.440,42 and a TI of less than
0.743,44 are considered to be of negligible risk of US-
induced biological effects for any examination dura-
tion. Simple instructions for implementing ALARA
are38: “Select the right transducer, start with a low
output level, and obtain the best image possible by
using focusing, receiver gain, and other imaging con-
trols. If that is not adequate for diagnostic purposes,
then increase the output level. We can further imple-
ment ALARA by reducing the total US exposure
time.” Diagnostic US may be used without reserva-
tion in most examinations for medical indications or
for appropriate POCUS practitioner training.45–47
However, ALARA should include the elimination of
diagnostic US exposure with no medical purpose or
benefit.
Safety Considerations for Specific POCUS
Examinations
The possible risk varies greatly for different imaging
modes, examination regions in the body, patient habi-
tus, and health statuses. A reasonable application of
ALARA to diagnostic US should include adjustment
of exposure index values or the duration of the exami-
nation at hand by knowledgeable sonographers.
The following considerations of various types of
POCUS examinations help guide the safe use of
diagnostic US.
Imaging Involving Low-Absorption Tissue Without
Gaseous Nuclei
Many POCUS examinations are performed in adult
tissues with low absorption, giving a TIS of less than
2, and no bodies of gas (Table 1).48 The liver and
kidney are commonly examined for abnormal masses
and blood flow. The heart is examined by echocardi-
ography for assessment of function. Small-parts imag-
ing provides excellent images that can be presented at
magnified image scales and typically do not include
bone or bodies of gas. Focused assessment with sonog-
raphy in trauma examinations can detect blood in the
abdomen and pericardium (for lung, see the “Pulmo-
nary POCUS” section below). Diagnostic interven-
tional US for guided vascular access or fine-needle
Miller et al—Safety Review for Point-of-Care Ultrasound
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aspiration is excellent for reduction of potential patient
injury through control of the penetrating needle. Tissues
in the body wall, including intercostal spaces and the
abdominal wall, likewise have no bone or gas bodies in
the imaging path.
Critically, the body does not appear to contain
optimum cavitation nuclei for diagnostic US, likely
because of the complete wetting and sterilization pro-
cesses active in living tissue. Research on the occur-
rence of inertial cavitation in response to diagnostic
US imaging of normal tissue has been negative, indicat-
ing that inertial cavitation–induced injury is nonexis-
tent or very rare for diagnostic US without the
presence of microbubble contrast agents. Therefore,
the MI should be considered a general nonthermal
exposure index, rather than a specific cavitation index
(except for contrast-enhanced diagnostic US, discussed
below).
These examinations also typically use imaging
with low TI values (low temporal-average intensity)
even at the maximum output. Heating is least for the
low-absorption soft tissues (ie, other than bone or the
cranium) and presents minimal risk of injury, particu-
larly in adults, for a TI of less than 2, even for lengthy
exposure times, as listed in Table 3. Therefore, the risk
of injury from the thermal mechanism is also very low.
For low-absorption tissue without gaseous nuclei,
the maximum output can be used with a very low risk
of patient injury from the US exposure. The ALARA
principle should still be applied when reduced-output
imaging produces diagnostically optimal images to
avoid higher exposures with no additional medical
value.
Contrast-Enhanced POCUS
The use of US contrast agents to improve suboptimal
US images and provide additional diagnostic informa-
tion can be useful in several different situations, such
as echocardiography and assessment of liver
masses.49,50 Contrast-enhanced diagnostic US
requires venous access for contrast agent injection
along with coordinated timing of the injection and
imaging. Contrast agents are suspensions of stabilized
microbubbles, which are designed for long circulation
times and a strong echo response.
Contrast-enhanced diagnostic US has a known
potential risk factor due to cavitation nucleation from
the stabilized microbubbles.51 This risk can be miti-
gated by the use of low-MI imaging modes (MI <0.4)
designed for microbubble persistence and optimal con-
trast enhancement. However, there are also non–US-
related risks, although rare, such as injection site com-
plications, complement activation related pseudoallergy,
and other anaphylactoid and allergic reactions.40,50
The use of contrast enhanced US is beginning to
expand into the point-of-care setting, focusing on car-
diac and trauma-related indications.52,53 However,
given the complex interaction of contrast agents,
examination protocols, and system settings that can
alter the cavitation risk, detailed safety parameters are
beyond the setting of this review. In general, for imag-
ing with contrast agents at an MI of greater than 0.4,
practitioners should use the minimal agent dose, MI,
and examination time consistent with efficacious
acquisition of diagnostic information.
Head and Musculoskeletal Examinations With Bone
and High-TI Modes
Musculoskeletal POCUS can be valuable for numer-
ous diagnoses in head and musculoskeletal examina-
tions (Table 1). A classic example of an important
diagnosis perfectly suited to POCUS is an examina-
tion for rib fractures. Griffith et al54 found that rib US
was better at detecting rib fractures than chest radiog-
raphy. Additional uses include assessment for skull
fracture, neonatal interventricular hemorrhage, trans-
cranial Doppler, fluid in the sinuses, etc.
These examinations are not expected to involve a
cavitation risk. However, bone and tendon have high
absorption coefficients and will heat faster and to
higher temperatures than soft tissue. The TIB should
be used for guidance when examinations involve bone,
Table 3. Recommended Limitations on Exposure Time for High-TI
Settings of the Appropriate TIS, TIB, or TIC
TI Range, C
Adult Scanning
Time, min
Obstetric Scanning
Time, min
>6 Not Recommended Not recommended
5.0–6.0 <0.25 Not recommended
4.0–5.0 <1 Not recommended
3.0–4.0 <4 Not recommended
2.5–3.0 <15 <1
2.0–2.5 <60 <4
1.5–2.0 <120 <15
1.0–1.5 No time limit <30
0.7–1.0 No time limit <60
<0.7 No time limit No time limit
Miller et al—Safety Review for Point-of-Care Ultrasound
8 J Ultrasound Med 2019; 9999:1–16
and the TIC should be used for examinations of the
head. For high-TI (>0.7) conditions, the exposure time
should be limited during an examination. A multistep
system is shown in Figure 3 and Table 3.44,55 In febrile
patients, the temperature elevation should be added to
the on-screen TI to determine the exposure time. The
exposure time limit decreases exponentially with an
increasing TI (the horizontal scale in Figure 3 is loga-
rithmic). Sonographers encountering higher TI values
may advantageously reduce the TI (power output) to
avoid hurried performance of difficult examinations.
For a TI of 5, a 50% reduction in power (–3 dB, equiv-
alent to an MI reduction, for example, from 1.4 to 1.0)
cuts the TI in half, thereby allowing an exposure time
of 1 hour rather than 1 minute.
Ophthalmic POCUS
Ocular US is used at the bedside to diagnose many
ophthalmic conditions, including intraocular or peri-
orbital foreign bodies, globe rupture, hyphema, lens
dislocation, lens subluxation, retinal detachment, reti-
nal hemorrhage, vitreous detachment, vitreous hemor-
rhage, choroidal detachment, papilledema, increased
intracranial pressure, neoplasms, and vascular disor-
ders.56,57 The examination typically is conducted with
a 7–15-MHz, small-footprint linear transducer coupled
to the closed eyelid with a copious amount of gel to
permit successful visualization without excessive pres-
sure to the globe. If the US device lacks an “ophthal-
mic” preset, then frequently a “small-parts” preset is
chosen. B-mode imaging is used for identifying ana-
tomic abnormalities and the presence and location of
foreign bodies, whereas Doppler US, both color and
spectral, finds use in examining blood flow in the oph-
thalmic and central retinal arteries and veins.56
The possibility of both thermal and nonthermal
bioeffects should be considered in the eye. In a review
by van Rhoon et al,58 safe thresholds for the tempera-
ture rise in various tissues and organs, including the eye,
were expressed in terms of a thermal dose of cumulative
effective minutes at 43C (CEM43). The most sensitive
eye structures were the lens, cornea, and retina, with the
lowest CEM43 value being 2.4 minutes for the lens.
One could base temperature-exposure time thresholds
on this value or, alternatively, take a more conservative
thermal dose-based approach by using the American
Institute of Ultrasound in Medicine’s “Statement on
Mammalian Biological Effects of Ultrasound In Vivo”42
for fetal exposures to set a CEM43 of 0.125 minutes for
the eye. The eye and early first-trimester embryo have
some comparable characteristics in that they can have a
similar size; neither is well perfused; and protein is pre-
sent.59 However, a practical problem with either of these
thermal dose approaches is that users only have access
to the TI, not the actual temperature rise, and studies
have found that the TIS could greatly underestimate the
actual temperature rise in the eye.60,61 The likely reason
is that the generic tissue models used for the TIS are
not appropriate for the eye, chiefly because of the rela-
tively large absorption in the lens and orbital fat; also,
the eye is poorly perfused. To offer some guidance, the
British Medical Ultrasound Society has recommended
not to exceed a TI of 1 when scanning the eye.62
Regarding nonthermal bioeffects, the eye nor-
mally has no gas body content. However, there are
some clinical situations, such as trauma, surgery, or
after the use of perfluorocarbon gases for treatment
of retinal detachment, in which gas bodies might be
present.63 In these cases, the risk of cavitational non-
thermal effects is possible.
Development of TI and MI recommendations for
eye examinations is challenging because the aforemen-
tioned generic tissue models used for calculating these
indices are not applicable to the eye. For this reason,
the FDA diagnostic US guidance23 has lower rec-
ommended maximum exposure levels for ophthalmic
examinations of an ISPTA.3 of 50 mW cm
–2 or less, MI
of 0.23 or less, and TI of 1 or less for devices that follow
Figure 3. Recommended TI versus exposure time safety guidance
for the appropriate TIS, TIB, or TIC (Table 2). Note that on the loga-
rithmic time scale, small changes in the TI result in large changes
in the recommended time limit.
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the output display standard (Table 2). Temperature rise
measurements in the eye due to US exposure have been
described in several articles, which indicate that the risk
of thermal injury is mitigated by the FDA guidelines for
ophthalmic examinations.61,63,64 Silverman et al63 stud-
ied the safety of very high-frequency diagnostic US
(US biomicroscopy) at 38 MHz and found no injury in
histologic specimens for up to 30 minutes of exposure
of a rabbit cornea or lens with an ISPTA.3 of 34 mW cm
–
2 (ie, less than the FDA recommended limit of 50 mW
cm–2). In general, the eye should only be evaluated if
there is an ophthalmologic preset on the system. If an
ophthalmologic setting is not available, the patient
should be informed that the scan is an off-label use and
give appropriate informed consent.
Pulmonary POCUS
The first accepted use of pulmonary diagnostic US
was to rule out pneumothorax.65 Subsequently, diag-
nostic US has been found to be valuable in the diag-
nosis of pneumonia, pulmonary edema, pulmonary
embolism, atelectasis, diffuse parenchymal disease,
respiratory distress syndrome, and lung cancer.66 The
pleura appears in the image as a hyperechoic line.
Artifacts are used to facilitate a variety of diagnoses,
including B-lines (comet tail artifacts), which are
diagnostic for pulmonary edema or interstitial lung
disease.67 Chest US is used in children for the diagno-
sis of neonatal respiratory distress syndrome,68
pneumonia,69–71 and other neonatal pulmonary dis-
eases for which POCUS is used.72 The assessments of
B-lines and other image features are valuable in neo-
natal examinations for diagnosis of respiratory distress
syndrome,73 assessing surfactant treatment,74 and pul-
monary hemorrhage,75 and the number of B- lines
correlates with computed tomographic findings.76
The total use of pulmonary diagnostic US is impossi-
ble to determine because POCUS examinations are
performed in so many settings and often routinely on
a daily basis to follow patient progress.
The biological effect of pulmonary capillary hemor-
rhage (PCH) produced by pulsed US exposure relevant
to diagnostic imaging was discovered more than
25 years ago in mice77 and has been confirmed in mice,
rats, rabbits, pigs, and monkeys. Direct human bioeffect
research ethically cannot be done, although an early
clinical study (B-lines were not yet established as a lung
US finding) was conducted to check for PCH on lungs
of adult humans undergoing transesophageal echocardi-
ography with exposure of the lung and thoracotomy,
allowing lung examinations.78 No hemorrhage was
noted by the surgeon on gross examinations of the
lungs. Recent results on the induction of PCH from
diagnostic US imaging in rats were comparable to early
results with laboratory pulsed US, and the US images
displayed B-lines associated with the occurrence and
progression of this bioeffect.79,80 Animal research has
shown that the PCH bioeffect depends on physical
parameters, such as the US mode81 and duration,82 in
addition to the MI. Biological factors also are very
important, including sedation,83 ventilation,84 age and
lung position,85 and animal species.86
The physical mechanism for the PCH bioeffect is
uncertain because both the thermal mechanism and
cavitation have been ruled out, and a nonthermal
mechanism such as acoustic radiation force or pres-
sure may be important.87 The most recent consensus
report of the American Institute of Ultrasound in
Medicine88 states that, although it was clear that
PCH might occur during realistic diagnostic expo-
sures above an MI of 0.4, patient risk should be mini-
mal for diagnostic US because only incidental lung
exposure was expected. However, as noted above,
pulmonary diagnostic US is now routine and widely
performed using portable point-of-care machines.
Clear application of the ALARA principle is needed.
Unfortunately, the B-line sign of PCH induction
is not useful for safety guidance. The possibility of
PCH induction for pulmonary examinations with an
MI of greater than 0.4 likely can be excluded when
no B-lines are seen, although very small PCH can
escape detection.82 However, the possibility of US
PCH induction for pulmonary examinations with an
MI of greater than 0.4 cannot be excluded when B-
lines are seen because of ambiguity in the origin and
persistence of the B-lines. B-line artifacts being sought
for diagnostic indications and those being induced by
the diagnostic US itself would be impossible to clearly
distinguish, particularly in clinical examinations,
because of the large variation in B-line appearances
with lung sliding and hand motion of the transducer.
The prudent safety guidance for pulmonary US is
to practice ALARA with an MI of less than 0.4 in many
patients. Because the lung surface is often at a shallow
depth, 0.7 cm even in some adults,89 pulmonary images
may be obtained at a reduced MI. An additional safety
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margin exists for many pulmonary examinations, such
as in high–body mass index patients, because the inter-
costal tissue has a relatively high absorption coefficient
of about 1.2 dB cm–1 MHz–1 (which is higher than the
value [0.3] assumed for the MI). The actual exposure
at the pleura will be less than that indicated by the on-
screen MI. For a chest wall thickness of 4 cm and a US
frequency of 6 MHz, not an uncommon configuration,
the exposure implied by the on-screen MI could be less
by a factor of 10 at the visceral pleura, mitigating the
risk of lung injury for an MI of greater than 0.4. These
considerations should be factored into the patient-
specific application of the ALARA principle, consistent
with acquisition of diagnostically acceptable images.
Obstetric POCUS
Ultrasound is the imaging modality of choice for
obstetrics and gynecology–related emergencies, as it
can be used to rapidly identify the uterus and its con-
tents. In addition, the adnexa can be evaluated, and the
pelvis can be assessed for the presence of free fluid.
Trans-abdominal US scanning will be the first
approach, but transvaginal US will often be needed for
its superior resolution. Common causes of acute lower
abdominal pain in female patients include ovulation
pain, ovarian torsion, hemorrhagic cysts, endometri-
osis, pelvic inflammatory disease, ectopic pregnancy,
issues with an intrauterine contraceptive device,
degenerating fibroids, as well as nongynecologic causes
such as appendicitis. In obstetrics, POCUS can be used
as a straightforward and accurate method to visualize
an intrauterine pregnancy from 5 to 6 weeks’ gestation
to term. One of the most common indications for
POCUS is abdominal pain in a patient with a positive
pregnancy test result. In addition to location of the
pregnancy, US can be used to confirm viability (pres-
ence of a fetal heartbeat), fetal number, and gestational
age and, later in pregnancy, to assess the fetal presenta-
tion, growth, and well-being as well as the placental
location, cervical length, and quantity of amniotic
fluid.90 Ultrasound is also used for prenatal imaging of
fetal ocular and orbital abnormalities.91
Althoughtherearenoconcernswith theuseofUS in
gynecology, whenever there is the possibility of an intra-
uterine pregnancy, caution should be exercised.59 The
developingfetusismostlysusceptibletoexternalinsultsin
thefirst10to12 weeksofpregnancy, thetimeofembryo-
genesis/organogenesis. The use of prenatal US for
inspectionoftheeyesalsointroduces thesafetyconsider-
ations for the eye, noted above in the “Ophthalmic
POCUS”section. Importantly, a20-year follow-upstudy
of a randomized controlled trial found thatno significant
impactonvisualoutcomesorocularbiometrywasassoci-
ated with frequent in utero US (B-mode and spectral
Dopplermode, likely including ocular exposure).92 The
occurrenceof cavitational bioeffects orpulmonary capil-
lary injury in the fetus is unlikelybecauseof an absenceof
cavitation nuclei and the lack of gas in the fetal lungs and
bowels.However,heat isaknownteratologicagent, from
animalresearchaswellas fromthedescribed incidenceof
fetal anomalies in humanmothers with an elevated tem-
peraturefrominfectionearlyinpregnancyorsecondaryto
anexcessiveuseofhotbathsorsaunas.Therefore,precau-
tion is necessary, particularly inmodes that can generate
higher acoustic outputs, such as the spectral (pulsed)
Doppler mode. This has led to a joint statement rec-
ommendingagainsttheroutineuseofpulsedDopplerUS
inthefirst trimester.39InkeepingwiththeALARAprinci-
ple, this would advocate for using the M-mode and not
using the pulsed Doppler mode for measurement of the
fetalheartratealone.
The general recommendation should be to keep
the examination as short as possible, with acoustic
outputs as low as possible but sufficient to arrive at
the correct diagnosis (ALARA principle). The TIS
should be used before 10 weeks and the TIB after
10 weeks. Detailed advice on the maximum scanning
time for a given TI is listed in Table 3. As for the
adult case, a reduction in output can greatly lengthen
the recommended scanning time limit. For example, a
reduction in output power of 50% for a TI of approxi-
mately 3 reduces the TI to approximately 1.5, thereby
allowing an exposure time of up to 30 minutes rather
than less than 1 minute.
Discussion of US Safety in the POCUS
Perspective
Reduction in the Ionizing Radiation Dose
This review has focused on safety considerations for
nonionizing US exposure. However, it should be noted
that POCUS has no risk of bioeffects such as cancer
and no trend for increasing risk with exposure accumu-
lation, as are well known for ionizing radiation doses.
This feature of a US examination provides an overall
Miller et al—Safety Review for Point-of-Care Ultrasound
J Ultrasound Med 2019 11
benefit by reducing the ionizing radiation dose. Point-
of-care US is growing throughout all medical specialties,
including pediatrics. Historically, US in pediatrics was
used in traditional ways by both radiology and cardiol-
ogy. The goal of bedside US, also known as POCUS, is
to provide real-time information to clinicians at the
point of care to guide medical decision making and pro-
vide procedural guidance. It is well established that radi-
ation exposure in children has long-term effects.93–97
The use of US can reduce the ionizing radiation expo-
sure substantially. For example, POCUS has proven to
be of value for monitoring Crohn disease in children98
and can greatly reduce the cumulative ionizing radiation
dose over the long course of this disease.99
Hands-on Training for High-Quality POCUS
The most important factor for POCUS efficacy and
safety is operator training. Physicians and other medi-
cal personnel who may use POCUS must understand
the principles of US imaging, the use of the exposure
indices, and how to produce images of diagnostic
value. Missed or incorrect diagnoses can have substan-
tial adverse consequences for the patient. Numerous
training guides are available, for example, in surgery
residency,100 anesthesiology,101 pediatrics,102 emer-
gency medicine,18 resource-limited emergency
physicians,103 critical care,19 and clinical practice.104
Hands-on training is critical and represents an impor-
tant medical application of diagnostic US (with atten-
tion to potential incidental findings of medical
importance).46,47 Ultrasound imaging has become
more and more clear and accurate but will show noth-
ing of value in the wrong hands. A particularly exciting
aspect of POCUS is that appropriate training including
safety and image interpretation potentially can be given
to many nonphysician medical personnel and can bring
the benefits of POCUS to virtually any patient in need:
for example, in remote rural areas.105,106
Summary of POCUS Safety Guidance
Diagnostic US exposure is regulated for safety, and
US may be used without reservation in most examina-
tions for medical indications or for appropriate
POCUS practitioner training. Nonmedical uses
should be minimized or avoided.45 No diagnostic
US–induced adverse biological effects have been
demonstrated or confirmed in humans, but very little
definitive human experimentation has been per-
formed (because of problematic ethics and low sensi-
tivity). Based on theoretical considerations and
definitive animal studies, special attention and pru-
dent use of the ALARA principle should be consid-
ered in 3 situations. The eye is particularly vulnerable
and has special, separate FDA guidelines (Table 2),
which must be set by the user for most US machines.
The surface of the lung is excellent for a diagnostic
examination but may have a risk of capillary hemor-
rhage in some patients who are thin or treated by
some medications. The fetus, as always, must pru-
dently be considered to be vulnerable and examined
with care by using the correct TI value for exposure
limitation. Sonographers themselves must practice
ALARA patient exposure during POCUS examina-
tions. Remembering these special situations may be
aided by the acronym SAFE (safety of the eye, lung,
and fetus).
Point-of-care US represents a revolution in patient
care with timely and high-value diagnostic information.
It is cost-effective and can fill the need for medical
imaging in many venues, including the most remote
settings. With few areas of concern for US exposure,
the use of POCUS can reduce patient exposure to ion-
izing radiation, which is an overall benefit for patient
safety. Continued growth and acceptance of POCUS
will provide optimum patient care.
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